TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 3 | 40 | 70 | 131 | 274 | 605 | 187 |
| P | %wins | 100 | 50 | 50 | 50 | 50 | 50 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/22/09 16:45 | 5/22/09 | KERX | Keryx Biopharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Kaye Jack | NY | D | P | 15 | 0.4290 | 0 | 35 | 57 | 96 | D | -97 | -29 | 94 | 169 | 119 | 40 | 6 | -8 | 5 | 81 | 152 | 264 | 561 | 999 | |
6/22/07 06:04 | 6/19/07 | KERX | Keryx Biopharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Kaye Jack | NY | D | P.d | 15 | 10.50 | 6 | 1 | New | 1 | I | -20 | -19 | -26 | -8 | -1 | -9 | -6 | -4 | 0 | -2 | -13 | -2 | -13 | -95 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |